Cinética y capacidad neutralizante de los anticuerpos homólogos y ...

Referencias Bibliográficas
56. Bhamarapravati N, Yoksan S. Study of bivalent dengue vaccine in volunteers.
Lancet 1989;1(8646):1077.
57. King AD, Nisalak A, Kalayanrooj S, Myint KS, Pattanapanyasat K, Nimmannitya
S, et al. B cells are the principal circulating mononuclear cells infected by dengue virus.
Southeast Asian J Trop Med Public Health 1999;30(4):718-28.
58. Kurane I, Janus J, Ennis FA. Dengue virus infection of human skin fibroblasts in
vitro production of IFN-beta, IL-6 and GM-CSF. Arch Virol 1992;124(1-2):21-30.
59. Lum LC, Lam SK, Choy YS, George R, Harun F. Dengue encephalitis: a true
entity? Am J Trop Med Hyg 1996;54(3):256-9.
60. Anderson R, Wang S, Osiowy C, Issekutz AC. Activation of endothelial cells via
antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol
1997;71(6):4226-32.
61. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. Dengue virus infection of
human endothelial cells leads to chemokine production, complement activation, and
apoptosis. J Immunol 1998;161(11):6338-46.
62. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, et al. Dengue
virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat
Med 1997;3(8):866-71.
63. Monath TP, Heinz FX. Flaviviruses. In: Fields BN, editor. Virology. Philadelphia-
New York: Lippincott-Raven; 1996. p. 961-1034.
64. Gubler DJ. Perspectives on the prevention and control of dengue hemorrhagic fever.
Gaoxiong Yi Xue Ke Xue Za Zhi 1994;10 Suppl:S15-8.
65. Savage HM, Fritz CL, Rutstein D, Yolwa A, Vorndam V, Gubler DJ. Epidemic of
dengue-4 virus in Yap State, Federated States of Micronesia, and implication of Aedes
hensilli as an epidemic vector. Am J Trop Med Hyg 1998;58(4):519-24.
66. McBride WJ, Bielefeldt-Ohmann H. Dengue viral infections; pathogenesis and
epidemiology. Microbes Infect 2000;2(9):1041-50.
67. Wang CH, Chang NT, Wu HH, Ho CM. Integrated control of the dengue vector
Aedes aegypti in Liu-Chiu village, Ping-Tung County, Taiwan. J Am Mosq Control Assoc
2000;16(2):93-9.
68. Monath TP. Early indicators in acute dengue infection. Lancet
1997;350(9093):1719-20.
69. Rico-Hesse R. Molecular evolution and distribution of dengue viruses type 1 and 2
in nature. Virology 1990;174(2):479-93.
70. Twiddy SS, Farrar JJ, Vinh Chau N, Wills B, Gould EA, Gritsun T, et al.
Phylogenetic relationships and differential selection pressures among genotypes of dengue-
2 virus. Virology 2002;298(1):63-72.
71. Lanciotti RS, Lewis JG, Gubler DJ, Trent DW. Molecular evolution and
epidemiology of dengue-3 viruses. J Gen Virol 1994;75 ( Pt 1):65-75.
72. Wittke V, Robb TE, Thu HM, Nisalak A, Nimmannitya S, Kalayanrooj S, et al.
Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period.
Virology 2002;301(1):148-56.
73. Lanciotti RS, Gubler DJ, Trent DW. Molecular evolution and phylogeny of dengue-
4 viruses. J Gen Virol 1997;78 ( Pt 9):2279-84.
74. Guzman MG, Kouri G. Dengue diagnosis, advances and challenges. Int J Infect Dis
2004;8(2):69-80.
124